5-((1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrol-3-yl)methylene)-2-(phenylimino)-3-propylthiazolidin-4-one

Catalog No. :
ACMQHX940
CAS No. :
404360-58-3
Molecular Formula :
C26H27N3O2S
Molecular Weight :
445.59

IUPAC Name:(2Z,5Z)-5-((1-(4-methoxyphenyl)-2,5-dimethyl-1H-pyrrol-3-yl)methylene)-2-(phenylimino)-3-propylthiazolidin-4-one

5-((1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrol-3-yl)methylene)-2-(phenylimino)-3-propylthiazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-((1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrol-3-yl)methylene)-2-(phenylimino)-3-propylthiazolidin-4-one
IUPAC Name(2Z,5Z)-5-((1-(4-methoxyphenyl)-2,5-dimethyl-1H-pyrrol-3-yl)methylene)-2-(phenylimino)-3-propylthiazolidin-4-one
Molecular FormulaC26H27N3O2S
Molecular Weight445.59
SMILESCCCN1C(=O)/C(=C/C2=C(C)N(C3=CC=C(OC)C=C3)C(C)=C2)S/C1=N\C1=CC=CC=C1
InChI KeyXMTUERJUKQHQAP-HXNPFYCNSA-N
Synonym(2Z,5Z)-5-{[1-(4-methoxyphenyl)-2,5-dimethyl-1H-pyrrol-3-yl]methylidene}-2-(phenylimino)-3-propyl-1,3-thiazolidin-4-one;4-Thiazolidinone, 5-[[1-(4-methoxyphenyl)-2,5-dimethyl-1H-pyrrol-3-yl]methylene]-2-(phenylimino)-3-propyl-
CAS No.404360-58-3

Synthetic Route by SureRoute

1. ACMQHX940 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMQHX940 route product structure diagram
    ACMQHX940404360-58-3
Inquiry

2. ACMQHX940 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSIGC147 route compound structure diagram
    ACSIGC14720265-97-8 In Stock
  4. Then
  5. ACMQHX940 route product structure diagram
    ACMQHX940404360-58-3
Inquiry

Comments (0)